-Reuters
Calif. Rep Katie Porter Says Concerned Avis May Have Engaged In Predatory Practices
-Earlier Bloomberg Report
Related Posts
FDA’s AdComm Gives Thumbs Down To Pediatric Cancer Therapy
FDA's Oncologic Drugs Advisory Committee (ODAC) raised concerns regarding the efficacy of Y-mAbs Therapeutics Inc's (NASDAQ: YMAB) potential pediatric neuroblastoma treatment, omburtamab.
Former Top Credit Suisse Shareholder Harris Associates Sold Entire Stake In Bank
-Financial Times
https://www.ft.com/content/9eaa4394-3647-4ac3-adbf-3bc73a4413a3
‘Exceptional Unit Level Economics’: Analysts Initiate Coverage Of Dutch Bros Following Quiet Period
Dutch Bros Inc (NYSE: BROS) shares gained 15.7% on Monday, continuing the stock’s strong run following its September IPO.
Dutch Bros is off to a hot start to life on the public market and has now more than doubled its $23 IPO price.